Cogent Biosciences Inc. (COGT) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Cogent Biosciences Inc.

    NASDAQ: COGT · Real-Time Price · USD
    15.76
    1.01 (6.85%)
    At close: Oct 03, 2025, 3:59 PM
    16.21
    2.87%
    After-hours: Oct 03, 2025, 06:49 PM EDT

    Cogent Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 98.17M 53.23M 139.89M 219.68M
    Short-Term Investments
    		 188.91M 212.48M 119.39M n/a
    Long-Term Investments
    		 n/a 7.46M n/a 1.25M
    Other Long-Term Assets
    		 4.86M 4.86M 4.75M 3.73M
    Receivables
    		 n/a n/a n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 9.39M 5.06M 1.25M 2.95M
    Total Current Assets
    		 296.47M 270.77M 264.97M 222.63M
    Property-Plant & Equipment
    		 26.56M 30.34M 31.1M 4.48M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 31.43M 42.67M 35.84M 9.46M
    Total Assets
    		 327.9M 313.44M 300.81M 232.09M
    Account Payables
    		 12.01M 10.65M 5.84M 3.48M
    Deferred Revenue
    		 n/a n/a 1.7M 7.97M
    Short-Term Debt
    		 1.56M n/a 1.42M 2.32M
    Other Current Liabilities
    		 40.57M 10.31M 12.1M 5.56M
    Total Current Liabilities
    		 55.71M 38.17M 26.85M 17.08M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 15.9M 17.47M 18.23M 831K
    Total Liabilities
    		 71.61M 55.63M 45.08M 17.91M
    Total Debt
    		 17.47M 18.85M 19.65M 3.15M
    Book Value
    		 256.29M 257.8M 255.74M 214.18M
    Book Value Per Share
    		 2.47 3.24 4.35 5.53
    Common Stock
    		 110K 86K 70K 44K
    Retained Earnings
    		 -859.48M -603.62M -411.21M -270.97M
    Comprehensive Income
    		 447K 246K -104K -0.00
    Shareholders Equity
    		 256.29M 257.8M 255.74M 214.18M
    Total Investments
    		 188.91M 219.94M 119.39M 1.25M

    Add to Watchlist